Compare J.B.Chemicals with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ALEMBIC LTD - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ALEMBIC LTD J.B.CHEMICALS/
ALEMBIC LTD
 
P/E (TTM) x 22.4 31.8 70.3% View Chart
P/BV x 4.0 2.7 146.8% View Chart
Dividend Yield % 0.3 0.4 78.6%  

Financials

 J.B.CHEMICALS   ALEMBIC LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
ALEMBIC LTD
Mar-18
J.B.CHEMICALS/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs36372 504.3%   
Low Rs25534 752.2%   
Sales per share (Unadj.) Rs169.14.7 3,598.3%  
Earnings per share (Unadj.) Rs16.66.1 272.0%  
Cash flow per share (Unadj.) Rs23.46.2 375.0%  
Dividends per share (Unadj.) Rs2.000.20 1,000.0%  
Dividend yield (eoy) %0.60.4 171.3%  
Book value per share (Unadj.) Rs172.540.7 424.2%  
Shares outstanding (eoy) m83.57267.03 31.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.811.3 16.2%   
Avg P/E ratio x18.68.7 214.6%  
P/CF ratio (eoy) x13.28.5 155.7%  
Price / Book Value ratio x1.81.3 137.6%  
Dividend payout %12.03.3 367.7%   
Avg Mkt Cap Rs m25,82714,139 182.7%   
No. of employees `0003.8NA-   
Total wages/salary Rs m2,511207 1,210.7%   
Avg. sales/employee Rs Th3,747.4NM-  
Avg. wages/employee Rs Th665.7NM-  
Avg. net profit/employee Rs Th367.8NM-  
INCOME DATA
Net Sales Rs m14,1351,255 1,126.1%  
Other income Rs m366370 98.8%   
Total revenues Rs m14,5011,625 892.1%   
Gross profit Rs m2,178111 1,960.7%  
Depreciation Rs m57038 1,507.1%   
Interest Rs m352 2,052.9%   
Profit before tax Rs m1,940442 439.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m55224 2,306.1%   
Profit after tax Rs m1,3871,630 85.1%  
Gross profit margin %15.48.9 174.1%  
Effective tax rate %28.55.4 525.3%   
Net profit margin %9.8129.8 7.6%  
BALANCE SHEET DATA
Current assets Rs m10,4701,867 560.8%   
Current liabilities Rs m2,749591 465.0%   
Net working cap to sales %54.6101.6 53.7%  
Current ratio x3.83.2 120.6%  
Inventory Days Days5594 58.6%  
Debtors Days Days7874 105.6%  
Net fixed assets Rs m5,8111,791 324.5%   
Share capital Rs m167534 31.3%   
"Free" reserves Rs m14,24810,324 138.0%   
Net worth Rs m14,41610,858 132.8%   
Long term debt Rs m041 0.0%   
Total assets Rs m17,64911,591 152.3%  
Interest coverage x56.6260.9 21.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.1 739.6%   
Return on assets %8.114.1 57.2%  
Return on equity %9.615.0 64.1%  
Return on capital %13.715.2 90.2%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m6,16419 31,772.6%   
Fx outflow Rs m1,334264 505.8%   
Net fx Rs m4,829-244 -1,975.9%   
CASH FLOW
From Operations Rs m1,231236 521.8%  
From Investments Rs m-208-224 92.9%  
From Financial Activity Rs m-595-27 2,237.6%  
Net Cashflow Rs m427-15 -2,885.8%  

Share Holding

Indian Promoters % 55.4 64.0 86.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.2 1,695.0%  
FIIs % 3.9 9.7 40.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 26.1 141.8%  
Shareholders   30,437 54,701 55.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  CIPLA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

IndiGo March Quarter Results, Falling Gold Prices, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Extending gains for the sixth consecutive day, Indian stock markets edged higher on the back of high buying seen in banking and auto sector.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade?(Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 3, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - AUROBINDO PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS